ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
63 089,84
6,71%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. OncoSec Medical Incorporated (ONCS)

  7. OncoSec Medical Incorporated (ONCS) Actualités

ONCS

OncoSec Medical (ONCS)

OncoSec Medical Incorporated
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ONCS
DateHeureSourceTitreSymboleSociété
22/06/202314h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONCSOncoSec Medical Incorporated
25/05/202322h14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ONCSOncoSec Medical Incorporated
18/05/202315h31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ONCSOncoSec Medical Incorporated
10/04/202314h01Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ONCSOncoSec Medical Incorporated
03/04/202314h02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ONCSOncoSec Medical Incorporated
28/03/202312h02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ONCSOncoSec Medical Incorporated
14/03/202311h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONCSOncoSec Medical Incorporated
12/12/202222h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONCSOncoSec Medical Incorporated
02/12/202222h23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ONCSOncoSec Medical Incorporated
01/12/202222h57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ONCSOncoSec Medical Incorporated
01/12/202212h11Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ONCSOncoSec Medical Incorporated
29/07/202222h30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ONCSOncoSec Medical Incorporated
26/06/202214h25TipRanksDawson James Thinks OncoSec Medical’s Stock is Going to RecoverNASDAQ:ONCSOncoSec Medical Incorporated
15/06/202216h25TipRanksAnalysts Are Bullish on These Healthcare Stocks: OncoSec Medical (ONCS), DermTech (DMTK)NASDAQ:ONCSOncoSec Medical Incorporated
31/05/202222h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ONCSOncoSec Medical Incorporated
03/05/202221h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONCSOncoSec Medical Incorporated
18/03/202219h14TipRanksBTIG Thinks OncoSec Medical’s Stock is Going to RecoverNASDAQ:ONCSOncoSec Medical Incorporated
18/03/202219h02TipRanksBTIG Sticks to Its Buy Rating for OncoSec Medical (ONCS)NASDAQ:ONCSOncoSec Medical Incorporated
16/12/202115h15TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Immunic (IMUX), OncoSec Medical (ONCS)NASDAQ:ONCSOncoSec Medical Incorporated
08/11/202112h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ONCSOncoSec Medical Incorporated
29/10/202121h58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONCSOncoSec Medical Incorporated
30/06/202101h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONCSOncoSec Medical Incorporated
14/06/202114h30PR Newswire (US)OncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey Silverman, as Vice President of Product EngineeringNASDAQ:ONCSOncoSec Medical Incorporated
27/05/202114h30PR Newswire (US)OncoSec to Present at the Raymond James Human Health Innovation ConferenceNASDAQ:ONCSOncoSec Medical Incorporated
17/05/202114h30PR Newswire (US)OncoSec Appoints Robert M. Schinagl, Ph.D. as Vice President of Program and Alliance ManagementNASDAQ:ONCSOncoSec Medical Incorporated
15/04/202114h30PR Newswire (US)OncoSec to Present Encore Interim Data from the KEYNOTE-695 Phase 2b Clinical Trial at the 10th World Congress of MelanomaNASDAQ:ONCSOncoSec Medical Incorporated
14/04/202114h30PR Newswire (US)OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse™" for the Treatment of Solid Tu...NASDAQ:ONCSOncoSec Medical Incorporated
25/03/202113h39PR Newswire (US)OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1 Checkpoint Refractory Metastatic MelanomaNASDAQ:ONCSOncoSec Medical Incorporated
01/03/202115h00PR Newswire (US)OncoSec Announces Publication in Clinical Cancer Research of Data Supporting the Therapeutic Potential of Lead Product Candid...NASDAQ:ONCSOncoSec Medical Incorporated
23/02/202115h00PR Newswire (US)OncoSec Announces Approval of $2.5 Million in NJEDA NOL Program Tax BenefitsNASDAQ:ONCSOncoSec Medical Incorporated
 Showing the most relevant articles for your search:NASDAQ:ONCS

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
EU
EN
Bouygues
NASDAQ
MSFT
Microsoft
EU
HO
Thales
EU
ML
Michelin
EU
ORA
Orange
EU
AI
Air Liquide
EU
BN
Danone
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés